the Related Factors of Bariatric Surgery on Lipidemia
- Conditions
- Bariatric SurgeryLipidemia
- Interventions
- Procedure: sleeve gastrectomyProcedure: gastric bypass
- Registration Number
- NCT03689803
- Lead Sponsor
- First Affiliated Hospital of Jinan University
- Brief Summary
Obesity and related metabolic diseases have become a chronic disease that is a threat to human health. Bariatric surgery can effectively and long-term reduce excess body weight and relieve related metabolic diseases, including type 2 diabetes. Laparoscopic gastric bypass surgery and laparoscopic sleeve gastrectomy are commonly used in bariatric surgery. Laparoscopic sleeve gastrectomy due to simple operation, good weight loss, and metabolic disease control effect, which is more widely used. However, there are several studies that show an increased chance of gastroesophageal reflux disease after laparoscopic sleeve gastrectomy. Long-term gastroesophageal reflux may lead to Barrett's esophagus or esophageal cancer. Nowadays, the cause of gastroesophageal reflux disease after sleeve gastrectomy is not clear and precautionary measures are not precise.
In this study, prospective randomized controlled trials were conducted to explore the possible change of lipidemia after bariatric surgery and to explore ways to prevent bariatric surgery after bariatric surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1000
-For the choice of surgical approach, numerous studies have shown that BMI ≧ 45, the general choice of gastric bypass surgery, BMI <45, you can choose sleeve gastrectomy. The remission rate for T2DM, sleeve gastrectomy has a good result for young patients with shorter duration. In the investigator's country, the BMI less than 45 is majorities.
-BMI<27.5
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Lipidemia sleeve gastrectomy - Lipidemia gastric bypass -
- Primary Outcome Measures
Name Time Method preoperative of choleaterol Preoperate choleaterol in ml/dl
Postoperative of choleaterol at 3 months 3 months choleaterol in ml/dl
Postoperative of choleaterol at 6 months 6 months choleaterol in ml/dl
Postoperative of choleaterol at 1 year 1 year choleaterol in ml/dl
- Secondary Outcome Measures
Name Time Method Preoperative of triglyceride Preoperative triglyceride in ml/dl
Postoperative of triglyceride at 3 months 3 months triglyceride in ml/dl
Postoperative of triglyceride at 6 months 6 months triglyceride in ml/dl
Postoperative of triglyceride at 1 year 1 year triglyceride in ml/dl
Trial Locations
- Locations (1)
The frist affiliated hospital of Jinan University
🇨🇳Guangzhou, Guangdong, China